Jiexian Ma

4PUBLICATIONS
4CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 13, 2025
Novel model to predict risk of invasive fungal infection and fungal prophylaxis timing.

Xinyu Zuo, Xinyuan Ma, Miao Zhang

|Feb 13, 2025
Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block.

Jiexian Ma, Shunrong Sun, Yanhui Xie

|Jul 25, 2022
Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL.

Jiexian Ma, Shunrong Sun, Yingwei Hu

|Feb 06, 2020
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients.

Wensi Qian, Li Wang, Pei Li

Pageof 1

Frequent Collaborators

1 joint publications

Yanhui Xie

1 joint publications

Xinyu Zuo

1 joint publications

Xinyuan Ma

1 joint publications

Richeng Mao